Skip to content
RadOncToday
  • Latest
  • About
The Weekly Five Search
The Radiation Oncology Feed For radiation oncologists · physicists · RTTs · dosimetrists

The RadOncToday newsletter

The Weekly Five

Five selected radiation oncology studies, with key findings, context and limitations. Free in your inbox every Sunday.

Check your inbox for an email from RadOncToday and follow the link to continue.

Free. One email every Sunday. Unsubscribe anytime.

Browse past issues ↓

Past issues

Explore the research →
Weekly Five

The Weekly Five | 9–15 November

Five studies worth your time this week, spanning brain metastases, Merkel cell carcinoma, nutritional support, breast radiotherapy and prostate SBRT.

RadOncToday · 15 Nov 2026 ·1 min read
Weekly Five

The Weekly Five | 2–8 November

Five studies worth your time this week, spanning lung SBRT, brain metastases, thoracic reirradiation, AI contouring and prostate dose escalation.

RadOncToday · 8 Nov 2026 ·1 min read
Weekly Five

The Weekly Five | 26 October – 1 November

Five studies worth your time this week, spanning lung SBRT, prostate fractionation, feeding-tube strategies, plasmacytoma treatment and metastasis-directed therapy.

RadOncToday · 1 Nov 2026 ·1 min read
Weekly Five

The Weekly Five | 19–25 October

Five studies worth your time this week, spanning randomized breast radiotherapy, lung reirradiation, late brain toxicity, treatment sequencing and cardiac risk.

RadOncToday · 26 Oct 2026 ·1 min read
Weekly Five

The Weekly Five | 12–18 October

Five studies worth your time this week, spanning randomized breast radiotherapy, secondary malignancies, adjuvant treatment decisions, long-term toxicity and proton selection.

RadOncToday · 18 Oct 2026 ·1 min read
Weekly Five

The Weekly Five | 5–11 October

Five studies worth your time this week, spanning randomized evidence, long-term toxicity, salvage treatment, surveillance and particle-therapy QA.

RadOncToday · 11 Oct 2026 ·1 min read
Weekly Five

The Weekly Five | ASTRO 2026 Special

Five randomized trials from ASTRO 2026, covering SCLC, prostate cancer, liver tumors and brain metastases—with key findings and limitations.

RadOncToday · 4 Oct 2026 ·1 min read
Page 1 of 1
RadOncToday Independent research summaries. The Weekly Five every Sunday.
The Weekly Five Partnership enquiries
  • Contact
  • Privacy Policy
  • Terms

Editorial selection is independent. Paid placements are clearly labelled.

© 2026 RadOncToday